doptelet
swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenia - anti-hemorrágicos - doptelet é indicado para o tratamento da trombocitopenia grave em doentes adultos com doença crônica do fígado, que são programados para se submeter a um procedimento invasivo. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. corticosteróides, imunoglobulinas).
mulpleo (previously lusutrombopag shionogi)
shionogi b.v. - lusutrombopag - trombocitopenia - anti-hemorrágicos - mulpleo é indicado para o tratamento da trombocitopenia grave em doentes adultos com doença hepática crônica submetidos a procedimentos invasivos.
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopénica, idiopática - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 e 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 e 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
revolade
novartis biociencias s.a - eltrombopague olamina - outros produtos anti-hemorragicos
gattart 680 mg + 80 mg comprimido para mastigar
alkaloid - int. d.o.o. - carbonato de cálcio + carbonato de magnésio - comprimido para mastigar - 680 mg + 80 mg - carbonato de cálcio 680 mg ; carbonato de magnésio pesado 80 mg - ordinary salt combinations - n/a - duração do tratamento: longa duração
gattart 680 mg + 80 mg comprimido para mastigar
alkaloid - int. d.o.o. - carbonato de cálcio + carbonato de magnésio - comprimido para mastigar - 680 mg + 80 mg - carbonato de cálcio 680 mg ; carbonato de magnésio pesado 80 mg - ordinary salt combinations - n/a - duração do tratamento: longa duração
mavenclad
merck europe b.v. - cladribina - esclerose múltipla - imunossupressores - tratamento de pacientes adultos com esclerose múltipla recidivante altamente ativada (ms) conforme definido por características clínicas ou de imagem.
aubagio
sanofi-aventis farmacÊutica ltda - teriflunomida - imunomodulador
teriflunomida
natcofarma do brasil ltda - teriflunomida - imunomodulador
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - tumores do estromal gastrointestinal - agentes antineoplásicos - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.